Post-acute care and secondary prevention after ischaemic stroke

BMJ

Volumn 342, Issue 7802, 2011, Pages

  McArthur, K S ^a   Quinn, T J ^a   Higgins, P ^a   Langhorne, P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; BOTULINUM TOXIN; CALCIUM; CLOPIDOGREL; DIPYRIDAMOLE; ENOXAPARIN; GLITAZONE DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LOW MOLECULAR WEIGHT HEPARIN; PERINDOPRIL; PIOGLITAZONE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D; WARFARIN; FIBRINOLYTIC AGENT;

BLADDER TRAINING; BLEEDING; BLEEDING DISORDER; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; COMORBIDITY; COMPRESSION GARMENT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DELIRIUM; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPHAGIA; EMERGENCY CARE; FALLING; FEMUR FRACTURE; GASTROINTESTINAL SYMPTOM; HEALTH CARE DELIVERY; HEART ATRIUM FIBRILLATION; HIP FRACTURE; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; LENGTH OF STAY; LIFESTYLE; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN; PATIENT ASSESSMENT; PATIENT CARE; PATIENT MOBILITY; PELVIC FLOOR MUSCLE TRAINING; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION CARE; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; STROKE; STROKE UNIT; SURVIVAL RATE; URINE INCONTINENCE; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; HOSPITALIZATION; METHODOLOGY; MOBILIZATION; NEUROLOGIC EXAMINATION; NUTRITIONAL SUPPORT; RECURRENT DISEASE;

DIETARY SUPPLEMENTS; EARLY AMBULATION; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; NEUROLOGIC EXAMINATION; NUTRITIONAL SUPPORT; PATIENT DISCHARGE; RECURRENCE; SECONDARY PREVENTION; STROKE; VENOUS THROMBOSIS;

EID: 79954571329     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2083     Document Type: Review

References (34)

1. National Collaborating Centre for Chronic Conditions. Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). Royal College of Physicians, 2008.
2. Scottish Intercollegiate Guideline Network. Management of patients with stroke: identification and management of dysphagia. A national clinical guideline. 2010.
3. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;4:CD000197.
4. Govan L, Langhorne P, Weir CJ, Stroke Unit Trialists' Collaboration. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? Further analysis of a systematic review. Stroke 2007;38:2536-40. (Pubitemid 47329634)
5. Langhorne P, Pollock A, Stroke Unit Trialists' Collaboration. What are the components of effective stroke unit care? Age Ageing 2002;31:365-71. (Pubitemid 35174525)
6. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007;369:1347-55. (Pubitemid 46621092)
7. CLOTS Trials Collaboration, Dennis M, Sandercock PA, Reid J, Graham C, Murray G, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009;373:1958-65.
8. CLOTS Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke. Ann Intern Med 2010;153:553-62.
9. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet 2005;365:755-63.
10. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 2005;365:764-72.
11. Ellis G, Mant J, Langhorne P, Dennis M, Winner S. Stroke liaison workers for stroke patients and carers: an individual patient data meta-analysis. Cochrane Database Syst Rev 2010;5:CD005066.
12. Langhorne P, Taylor G, Murray G, Dennis M, Anderson C, Bautz-Holter E, et al. Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet 2005;365:501-6. (Pubitemid 40215733)
13. Quinn TJ, Paolucci S, Sunnerhagen KS, Sivenius J, Walker MF, Toni D, et al. Evidence-based stroke rehabilitation: an expanded guidance document from the European Stroke Organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008. J Rehab Med 2009;41:99-111.
14. Scottish Intercollegiate Guidelines Network. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention. A national clinical guideline. 2008.
15. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or tia: a meta-analysis. Stroke 2008;39:1358-63. (Pubitemid 351440719)
16. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51.
17. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
18. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
19. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation 2005;111:2233-40. (Pubitemid 40632440)
20. Algra A, De Schryver EL, van GJ, Kappelle LJ, Koudstaal PJ. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst Rev 2006;3:CD001342.
21. van WC, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-8. (Pubitemid 35340540)
22. Saxena R, Koudstaal P. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev 2004;4:CD000187.
23. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
24. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Eng J Med 2009;361:1139-51.
25. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
26. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-16. (Pubitemid 36092014)
27. Rothwell PM, Gutnikov SA, Warlow CP. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 2003;34:514-23. (Pubitemid 36206358)
28. Intercollegiate Stroke Working Party. National clinical guideline for stroke. Third ed. Royal College of Physicians, 2008.
29. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:776-85. (Pubitemid 38280858)
30. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
31. Amarenco P, Labreuche J, Lavalle P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-9. (Pubitemid 39565192)
32. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366:1279-89. (Pubitemid 41416583)
33. VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurology 2010;9:855-65.
34. Langhorne P, Sandercock P, Prasad K. Evidence-based practice for stroke. Lancet Neurology 2009;8:308-9.